Floatz logo

Daunorubicin

Myeloid Sarcoma

Kura Oncology, Inc.Phase 3Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
89/ 100

Competitive context

24 Active assets in the Myeloid Sarcoma cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Kura Oncology, Inc.
Phase 3BB
Mitoxantrone
Ruijin Hospital
Phase 3BB
ETOPOSIDE
St. Jude Children's Research Hospital
Phase 3BB
Venetoclax
Ruijin Hospital
Phase 2BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BB

View all 31 →

Same molecule, other indications

Daunorubicin is also rated in:

acute myeloid leukemia by FAB classificationDormant
BBB
Indicative ·
78 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
77 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →